Cannabis use disorder (CUD) is an underappreciated risk of using cannabis that affects~
10% of the 193 million cannabis users worldwide. The individual and public health burdens …

Abstract Background Comorbidity between Substance Use Disorders (SUDs) and major
depression is highly prevalent. This systematic review and meta-analysis aimed to estimate …

The American Psychiatric Association Practice Guideline for the Treatment of Patients With
Schizophrenia | American Journal of Psychiatry Psychiatry Online Skip main navigation Close …

Abstract The coronavirus disease-19 (COVID-19) global pandemic has already had an
unprecedented impact on populations around the world, and is anticipated to have a …

The American Psychiatric Association Practice Guideline for the Treatment of Patients With
Schizophrenia seeks to reduce these substantial psychosocial and public health …

Background Comorbid mental illnesses and substance use disorders are associated with
adverse criminal, social, and health outcomes. Yet, their burden is not reliably known among …

Background Even low levels of substance misuse by people with a severe mental illness
can have detrimental effects. Objectives To assess the effects of psychosocial interventions …

Schizophrenia and schizoaffective disorder are schizophrenia spectrum disorders that
cause significant disability. Among individuals who have schizophrenia or schizoaffective …

Background Differences between people with schizophrenia and psychiatrically healthy
controls have been consistently demonstrated on measures of retinal function such as …

The extremes of human experiences, such as those occasioned by classic psychedelics and
psychosis, provide a rich contrast for understanding how components of these experiences …